A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults
Clinical trial NCT06786520 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06786520
- Sponsor
- ViiV Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2027-03-09
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.